Leerink Partners Biopharma Private Company Connect Format: 1x1 Investor Meetings Date/Time: Tuesday, October 22 and Wednesday, October 23 Location: Virtual ...
Viking Therapeutics VKTX has outperformed the market over the past 5 years by 41.66% on an annualized basis producing an ...
It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...
MarketBeat on MSN10h
Is Viking Therapeutics Ready For Another Surge?Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in ...
13h
But Lilly isn't alone in the market, and in the coming years, this space could become more crowded. Today, Lilly competes ...
For Q2 2024, the Voya MidCap Opportunities Strategy underperformed its benchmark on a NAV basis due to unfavorable allocation ...
We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback